This review provides a route for constructing advanced IR-ECDs towards real-world applications in smart windows, IR sensors, thermal control and military camouflage.

Electrochromic devices (ECDs) exhibiting tunable optical and thermal modulation in the infrared (IR) region have attracted extensive attention in recent years due to their attractive application prospects in both military and civilian settings. However, considering the continuous energy supply needed for driving the device operation, it is desired to develop advanced IR-ECDs with low energy consumption. Herein, a flexible self-driven IR-ECD is constructed for achieving variable optical and thermal management in a low-energy mode. In this device, a built-in potential difference of 1.36 V exists between the EC polyaniline cathode and the aluminum foil anode. Consequently, there is a rapid and obvious increase in the IR reflectance of the device after connecting the two electrodes. Such a self-driven reflectance contrast is over 20% at the wavelength of 1500 nm, and the coloration efficiency of the device reaches up to 93.6 cm 2 C −1 . Meanwhile, the maximum apparent temperature modulation on the surface of the device reaches up to 5.6 °C. Then, the self-driven IR-ECD could recover to its original state driven by a solar cell, indicating good reversibility and stability. We anticipate that this work may provide a new insight into developing advanced self-driven IR-ECDs for applications in dynamic military camouflage and commercial thermal control.

Advanced glycation end products (AGEs) and the receptor for AGEs (RAGE) both play important roles in diabetic nephropathy (DN). Previous studies have identified glomerular mesangial cells (GMCs) injury as a key early risk factor in the development of DN. Kaempferitrin (KM) is a potent antioxidant with hypoglycemic action. Although KM is known to protect against AGE-induced damage in GMCs, the effects and the mechanisms by which they occur are poorly understood. In this study, cultured rat GMCs were exposed to AGE-induced oxidative stress (OS) to model DN in vitro. Reactive oxygen species (ROS) was analyzed by 2′,7′-dichlorofluorescin diacetate (DCFH-DA). Superoxide dismutase (SOD) and malondialdehyde (MDA) were studied using commercial kits. Mitochondrial membrane potential (Δψm) was measured by rhodamine 123. Hoechst 33258 and annexin V and propidium iodide (PI) double staining were performed to observe the apoptosis states in GMCs, whereas apoptosis and protective mechanism in AGE-induced GMCs were investigated by Western blot. The data revealed that KM effectively increased SOD activity, decreased MDA levels, suppressed ROS generation, and protected against OS in AGE-induced GMCs. Treatment with KM also inhibited the expression of collagen IV and transforming growth factor-β1 (TGF-β1), improved mitochondrial membrane potential recovery, and suppressed the mitochondrial/cytochrome c-mediated apoptosis pathway through the expression of anti-apoptotic factors in GMCs in vitro. These findings suggest that KM may be a new potential agent in the treatment of DN in future.

No abstract

Diabetes is the leading cause of end-stage renal disease because diabetic nephropathy (DN) develops in 30-40% of the patients. This study investigated the protective effect of the aqueous extract from leaves of Cyclocarya paliurus (Batal.) Iljinsk (ACP) on DN by inhibiting oxidative stress and aldose reductase (AR) activity. ACP was obtained by hot water extraction. The in vitro antioxidant capability and AR inhibition of ACP were investigated by employing various established systems. DN rats were used to assess the reno-protective effect of ACP. Results showed that the polysaccharide and total polyphenol contents of ACP were (479.3 ± 19.8) mg/g and (38.3 ± 2.3) mg/g, respectively. ACP exhibited strong antioxidant ability and AR inhibition in vitro and in vivo; furthermore, the inhibition mechanism of ACP in AR takes the form of uncompetitive inhibition. In addition, the animals treated with ACP showed significant amelioration of blood glucose, serum biomarkers related to renal function, urinary protein excretion, and histopathological changes in the kidney. The results suggest that ACP has a potential role in ameliorating renal damage involved in DN.